Therapeutic potential of BOLD-100, a GRP78 inhibitor, enhanced by ATR inhibition in pancreatic ductal adenocarcinoma.

BOLD-100 - Bold Therap

ceralasertib (AZD6738) - AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/40514666

Ah-Rong Nam; Do-Youn Oh; Hyo Jung Kim; Jae-Min Kim; Jeesun Yoon; Ju-Hee Bang; Kyoung-Seok Oh; Sea Young Choo; Su In Lee; Tae-Yong Kim; Yoojin Jeong

Jun 14, 2025